Immunological liver diseases in children

Area of Science:

• Hepatology
• Immunology
• Internal Medicine

Background:

• Autoimmune liver diseases involve inflammatory liver damage from the body's own immune system.
• Conditions include autoimmune hepatitis (AIH), autoimmune sclerosing cholangitis (ASC), and AIH post-liver transplant.
• Symptoms range from acute hepatitis-like presentations to insidious onset with nonspecific symptoms or portal hypertension complications.

Purpose of the Study:

• To review the characteristics, pathogenesis, and treatment of autoimmune liver diseases.
• To highlight diagnostic markers such as smooth muscle (SMA), nuclear (ANA), and liver kidney microsomal type 1 (LKM1) antibodies.
• To discuss the efficacy of current treatments and identify areas for further research.

Main Methods:

• Review of existing literature on autoimmune liver diseases.
• Analysis of diagnostic criteria, including antibody profiles (SMA, ANA, LKM1).
• Evaluation of treatment outcomes with immunosuppressants like prednisolone and azathioprine, and the role of liver transplantation.

Main Results:

• Autoimmune liver diseases are characterized by specific autoantibodies and immune system dysregulation.
• Early immunosuppressive therapy (prednisolone +/- azathioprine) shows favorable responses.
• Liver transplantation is the primary treatment for fulminant hepatic failure or advanced cirrhosis.

Conclusions:

• Prompt diagnosis and early immunosuppressive treatment are crucial for managing autoimmune liver diseases.
• The pathogenic mechanisms of AIH post-liver transplant require further elucidation.
• The roles of other immunomodulatory drugs (cyclosporin A, tacrolimus, ursodeoxycholic acid) need further definition in treatment protocols.